10X Genomics Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Well, we have 10x here and happy to be hosting 10x on our second panel and go ahead and get started. Today, from 10x, we have Serge Saxonov, CEO; and Justin McAnear, the CFO. Welcome.
And just a reminder, if you would like to ask a question in the audience, we have instructions on the screen there, and there are also instructions on the tables.
Questions & Answers
So maybe just to get started here, maybe focusing a little on the 2Q results. You had pretty strong placements in the quarter following your pricing adjustment on the Chromium Controller. Can you talk a little bit about the strategy and the increase in instrument placements in the quarter?
Sure. So this is Justin McAnear, CFO. We lowered the price of the Chromium Controller to $35,000 in advance of the launch of Chromium X to make sure that we had the product positioned appropriately in our new lineup of instruments. And as we noted on our Q2 call, that drove about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |